Belharra Therapeutics

Overview

Belharra Therapeutics is a biotechnology company based in San Diego, California, with additional offices in the San Francisco Bay Area. Founded in 2021, the company focuses on drug discovery by targeting previously "undruggable" proteins through its proprietary platform, Searchlight™. This innovative platform utilizes photoaffinity-based chemoproteomics to identify novel binding pockets on proteins, enabling the development of treatments for diseases in immunology and oncology.

The company has raised approximately $130 million in funding, including investments from Versant Ventures and Genentech. Its team consists of experts in medicinal chemistry, proteomics, data science, and chemical biology. Recent collaborations include a strategic partnership with Sanofi for small molecule discovery in immunology, valued at up to $700 million. The organization is dedicated to advancing early-stage drug discovery and developing first-in-class therapeutics for serious diseases.

Basic Information

Contact Details

• Phone: +1 858-800-4340
• Website: belharratx.com
• LinkedIn: linkedin.com/company/belharra-therapeutics

Key Focus Areas & Initiatives

• Drug discovery targeting undruggable proteins
• Photoaffinity-based chemoproteomics for binding pocket identification
• Early-stage therapeutics development for immunology and oncology
• Small molecule discovery partnerships
• Proteome-wide mapping and targeting protein interfaces
• Advancement of medicinal chemistry and chemical biology research
• Machine learning and AI-driven drug discovery

Technologies Used

• Micro
• Outlook
• Remote
• Slack

Affiliated Organizations & Regional Branches